Cenix BioScience GmbH conducts contract research and technology development focused on cell-based and in vivo applications of RNAi, miRNA modulation and high-content phenotyping to accelerate target discovery, target validation, and the non-clinical development of new drug candidates.
Cenix is an industry leader in performing RNAi-based Target Discovery screens, Target Validation studies, and Drug Mode of Action analyses in transformed or...